Derek Thomas Brown

USPTO Granted Patents = 11 (Patent Applications = 3)

CIPO Patents = 3

EPO Patents = 5 (Patent Applications = 4)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 131(Granted Patents)

Location History:

Eighton Bank, Gateshead, Tyne & Wear, GB (1982)
Eighton Banks, Gateshead 9, Tyne & Wear NE9 7BP, GB (1983)
Slough, GB (2007 - 2012)
Berkshire, GB (2014 - 2016)
Beenham, GB (2006 - 2017)

Company Filing History:

Celltech Chiroscience Limited

7. 2 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1982-2017

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9840556 - Anti-TNF alpha antibodies which selectively inhibit TNF alpha signalling through the p55R (2017-12-12),

2. 9321840 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2016-04-26),

3. 8784823 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2014-07-22),

4. 8293237 - Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof (2012-10-23),

5. 7993864 - Assay for identifying antibody producing cells (2011-08-09),

6. 7977464 - Antibody molecules specific to human tumour necrosis factor alpha (2011-07-12),

7. 7402662 - Antibody molecules specific to human tumor necrosis factor alpha (2008-07-22),

8. 7186820 - Production of humanised antibodies to TNFα (2007-03-06),

9. 7012135 - Biological products (2006-03-14),

10. 4370961 - Fuel rate control for internal combustion engines (1983-02-01),

11. 4316395 - Control apparatus for drive transmissions (1982-02-23),

Title: Unveiling the Innovative Mind of Derek Thomas Brown from Beenham, GB

Introduction:

Derek Thomas Brown, an accomplished inventor hailing from Beenham, GB, has left a remarkable imprint on the field of biopharmaceutical innovations. With a portfolio boasting nine patents, Derek is a visionary in the realm of antibody development and therapeutic proteins.

Latest Patents:

Among Derek's latest patents is the groundbreaking work on Anti-TNF alpha antibodies, which selectively inhibit TNF alpha signaling through the p55R. This invention offers a targeted approach in treating inflammatory conditions by focusing on specific TNF alpha pathways. Additionally, his research on binding proteins that specifically target CD154 has opened new avenues in diagnostic and therapeutic methods for immune-related diseases.

Career Highlights:

Derek Thomas Brown has been associated with renowned companies like UCB Pharma and UCB Biopharma Sprl, where he has contributed significantly to cutting-edge research and development in the biopharmaceutical sector. His expertise in antibody engineering and protein therapeutics has garnered recognition across the industry.

Collaborations:

Throughout his career, Derek has collaborated with esteemed professionals such as Andrew George Popplewell and Andrew Neil Charles Weir. These collaborations have led to synergistic efforts in advancing biopharmaceutical solutions for complex medical challenges, showcasing Derek's ability to thrive in a collaborative environment.

Conclusion:

In conclusion, Derek Thomas Brown stands as a prominent figure in the world of biopharmaceutical innovations, with a remarkable track record of patents that illustrate his commitment to pushing the boundaries of scientific discovery. His contributions in antibody research and therapeutic protein development continue to shape the landscape of modern medicine, leaving a lasting impact on the industry and the lives it touches.

This text is generated by artificial intelligence and may not be accurate.